Relay Therapeutics files to sell up to $213 million more shares via TD Cowen
The prospectus supplement expands Relay's at-the-market equity program after the company had already sold 16 million shares under the original agreement.
SEC filing
Latest
2 stories
Thursday, August 6
Relay Therapeutics amends ATM deal, adds legal opinion and Q2 results in same filing
An August 6, 2026 8-K details the finalized sales agreement amendment, a new Goodwin Procter legal opinion, and the company's furnished second-quarter financial results.
SEC filing